KRAS and medical procedure: It remains, therefore, that further more advanced KRAS testing, including next generation sequencing (NGS), on a large number of patients, particularly beyond the most common hotspot alleles in exons 2 and 3 is needed to explore the exact prognostic and predictive significance of the discovered novel mutations as well as their possible role in colorectal carcinogenesis.